Literature DB >> 3459296

Therapy for ocular bacterial infection.

J Baum.   

Abstract

This paper presents in large part the author's views on the treatment of a variety of bacterial infections of the eye. Emphasis is placed on the management of bacterial corneal ulcers and endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3459296

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  7 in total

Review 1.  Bacillus cereus endophthalmitis.

Authors:  D B David; G R Kirkby; B A Noble
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

Review 2.  Infectious endophthalmitis after cataract surgery.

Authors:  D S Hughes; R J Hill
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

3.  Contribution of saccadic motion to intravitreal drug transport: theoretical analysis.

Authors:  Ram K Balachandran; Victor H Barocas
Journal:  Pharm Res       Date:  2011-01-22       Impact factor: 4.200

4.  Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study.

Authors:  T Das; S Jalali; V K Gothwal; S Sharma; T J Naduvilath
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

5.  Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas.

Authors:  J A Hobden; D S Rootman; R J O'Callaghan; J M Hill
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

6.  Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model.

Authors:  J Frucht-Pery; G Golan; I Hemo; H Zauberman; M Shapiro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

Review 7.  Pharmacokinetic considerations in the treatment of bacterial keratitis.

Authors:  M C Callegan; R J O'Callaghan; J M Hill
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.